Literature DB >> 23078897

Radiation therapy to convert the tumor into an in situ vaccine.

Silvia C Formenti, Sandra Demaria.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23078897      PMCID： PMC3811126          DOI： 10.1016/j.ijrobp.2012.06.020

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  10 in total

Review 1.  Chemotherapy and radiotherapy: cryptic anticancer vaccines.

Authors:  Yuting Ma; Oliver Kepp; François Ghiringhelli; Lionel Apetoh; Laetitia Aymeric; Clara Locher; Antoine Tesniere; Isabelle Martins; André Ly; Nicole M Haynes; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal:  Semin Immunol       Date:  2010-04-18       Impact factor: 11.130

2.  Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma.

Authors:  H B Stone; L J Peters; L Milas
Journal:  J Natl Cancer Inst       Date:  1979-11       Impact factor: 13.506

3.  Immunologic correlates of the abscopal effect in a patient with melanoma.

Authors:  Michael A Postow; Margaret K Callahan; Christopher A Barker; Yoshiya Yamada; Jianda Yuan; Shigehisa Kitano; Zhenyu Mu; Teresa Rasalan; Matthew Adamow; Erika Ritter; Christine Sedrak; Achim A Jungbluth; Ramon Chua; Arvin S Yang; Ruth-Ann Roman; Samuel Rosner; Brenna Benson; James P Allison; Alexander M Lesokhin; Sacha Gnjatic; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

Review 4.  Natural innate and adaptive immunity to cancer.

Authors:  Matthew D Vesely; Michael H Kershaw; Robert D Schreiber; Mark J Smyth
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.

Authors:  Sandra Demaria; Noriko Kawashima; Anne Marie Yang; Mary Louise Devitt; James S Babb; James P Allison; Silvia C Formenti
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

6.  In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.

Authors:  Joshua D Brody; Weiyun Z Ai; Debra K Czerwinski; James A Torchia; Mia Levy; Ranjana H Advani; Youn H Kim; Richard T Hoppe; Susan J Knox; Lewis K Shin; Irene Wapnir; Robert J Tibshirani; Ronald Levy
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

Review 7.  Systemic effects of local radiotherapy.

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  Lancet Oncol       Date:  2009-07       Impact factor: 41.316

8.  Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.

Authors:  Sandra Demaria; Bruce Ng; Mary Louise Devitt; James S Babb; Noriko Kawashima; Leonard Liebes; Silvia C Formenti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

9.  The abscopal effect associated with a systemic anti-melanoma immune response.

Authors:  Emily F Stamell; Jedd D Wolchok; Sacha Gnjatic; Nancy Y Lee; Isaac Brownell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-05       Impact factor: 7.038

Review 10.  Local control by radiotherapy: is that all there is?

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  Breast Cancer Res       Date:  2008-11-05       Impact factor: 6.466
  10 in total
  112 in total

1.  Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery.

Authors:  Juan Carlos López Alfonso; Jan Poleszczuk; Rachel Walker; Sungjune Kim; Shari Pilon-Thomas; Jose J Conejo-Garcia; Hatem Soliman; Brian Czerniecki; Louis B Harrison; Heiko Enderling
Journal:  JCO Clin Cancer Inform       Date:  2019-04

Review 2.  In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology.

Authors:  Chenkai Mao; Michael-Joseph Gorbet; Akansha Singh; Ashish Ranjan; Steven Fiering
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

Review 3.  Combining immunotherapy with radiation for the treatment of glioblastoma.

Authors:  Kevin K H Chow; Wendy Hara; Michael Lim; Gordon Li
Journal:  J Neurooncol       Date:  2015-04-17       Impact factor: 4.130

Review 4.  Combining immunotherapy and radiotherapy in lung cancer.

Authors:  Neeraj Bhalla; Rachel Brooker; Michael Brada
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

5.  Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.

Authors:  Sibo Tian; Jeffrey M Switchenko; Zachary S Buchwald; Pretesh R Patel; Joseph W Shelton; Shannon E Kahn; Rathi N Pillai; Conor E Steuer; Taofeek K Owonikoko; Madhusmita Behera; Walter J Curran; Kristin A Higgins
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-01-24       Impact factor: 7.038

Review 6.  Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy.

Authors:  Jonathan Pol; Erika Vacchelli; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

7.  [Radiotherapy enhances the effect of PD-1 checkpoint inhibitors].

Authors:  René Baumann; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2017-09       Impact factor: 3.621

Review 8.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

Review 9.  Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Authors:  Erika Vacchelli; Norma Bloy; Fernando Aranda; Aitziber Buqué; Isabelle Cremer; Sandra Demaria; Alexander Eggermont; Silvia Chiara Formenti; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-07-25       Impact factor: 8.110

Review 10.  Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

Authors:  Michael B Bernstein; Sunil Krishnan; James W Hodge; Joe Y Chang
Journal:  Nat Rev Clin Oncol       Date:  2016-03-08       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.